The present disclosure provides pyrimidinone-phenyl-pyrimidinyl compounds useful in the treatment of p38 kinase mediated diseases, such as lymphoma and inflammatory disease, having the structure of Formula (I):
wherein R
1
, R
2
, R
3
, R
4
and R
5
are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating p38 kinase mediated diseases using the compound.
本公开提供了在治疗p38激酶介导的疾病(如淋巴瘤和炎症性疾病)中有用的
嘧啶酮-
苯基-
嘧啶基化合物,其具有如下式(I)的结构:
其中R1、R2、R3、R4和R5如详细描述中所定义;包括至少一种该化合物的药物组合物;以及使用该化合物治疗p38激酶介导的疾病的方法。